{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:10:30Z","timestamp":1779426630643,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmc.2026.118624","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:42:46Z","timestamp":1773049366000},"page":"118624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery and characterization of steroid derivatives as hCES2A inhibitors"],"prefix":"10.1016","volume":"137","author":[{"given":"Yueyang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Zhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118624_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jbt.20178","article-title":"Human carboxylesterases and their role in xenobiotic and endobiotic metabolism","volume":"21","author":"Ross","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.bmc.2026.118624_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.pharmtox.38.1.257","article-title":"The mammalian carboxylesterases: from molecules to functions","volume":"38","author":"Satoh","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bmc.2026.118624_bb0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.bmc.2026.118624_bb0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2026.118624_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2014.10.026","article-title":"Contribution of human esterases to the metabolism of selected drugs of abuse","volume":"232","author":"Meyer","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bmc.2026.118624_bb0030","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1021\/jm900694z","article-title":"Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine","volume":"52","author":"Barthel","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0035","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.cclet.2022.01.087","article-title":"Lysosome-targeting red fluorescent probe for broad carboxylesterases detection in breast cancer cells","volume":"33","author":"Sun","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmc.2026.118624_bb0040","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1021\/acs.jmedchem.3c01850","article-title":"Tight-binding small-molecule carboxylesterase 2 inhibitors reduce intracellular irinotecan activation","volume":"67","author":"Kailass","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2006.07.001","article-title":"Structure, function and regulation of carboxylesterases","volume":"162","author":"Satoh","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118624_bb0050","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/13543776.2011.586339","article-title":"Carboxylesterase inhibitors","volume":"21","author":"Hatfield","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2026.118624_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/0929867033368619","article-title":"Lessons learned from the irinotecan metabolic pathway","volume":"10","author":"Ma","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0060","first-page":"4983","article-title":"Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis","volume":"9","author":"Sanghani","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2026.118624_bb0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00280-006-0187-8","article-title":"Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea","volume":"58","author":"Takasuna","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmc.2026.118624_bb0070","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1021\/acs.jmedchem.4c02560","article-title":"AI-driven discovery of highly specific and efficacious hCES2A inhibitors for ameliorating irinotecan-triggered gut toxicity","volume":"68","author":"Sang","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0075","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/jm049011j","article-title":"Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases","volume":"48","author":"Wadkins","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0080","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0006-2952(69)90050-1","article-title":"Inhibition of phenacetin- and acetanilide-induced methemoglobinemia in the rat by the carboxylesterase inhibitor bis-[p-nitrophenyl] phosphate","volume":"18","author":"Heymann","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118624_bb0085","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/jpet.104.081265","article-title":"Hydrolysis of capecitabine to 5\u2032-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide","volume":"313","author":"Quinney","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2026.118624_bb0090","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/jm061471k","article-title":"Selective inhibition of carboxylesterases by isatins, indole-2,3-diones","volume":"50","author":"Hyatt","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116187","article-title":"Discovery of pyrazolones as novel carboxylesterase 2 inhibitors that potently inhibit the adipogenesis in cells","volume":"40","author":"Qian","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0100","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1124\/mol.65.6.1336","article-title":"Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity","volume":"65","author":"Wadkins","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2026.118624_bb0105","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1021\/jm101101q","article-title":"Structure\u2013activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitors","volume":"53","author":"Young","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104367","article-title":"Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2","volume":"105","author":"Zhao","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2016.02.020","article-title":"Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2","volume":"112","author":"Zou","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0120","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.114.056994","article-title":"Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmc.2026.118624_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/np300628a","article-title":"Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza (\u201cDanshen\u201d)","volume":"76","author":"Hatfield","year":"2013","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2026.118624_bb0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/acs.jmedchem.5c03005","article-title":"Approved steroidal drugs (2000\u20132025): a medicinal chemistry perspective","volume":"69","author":"Zhu","year":"2026","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116333","article-title":"Drug development and potential targets for Cushing\u2019s syndrome","volume":"270","author":"Wei","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0140","doi-asserted-by":"crossref","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","article-title":"The SWISS-MODEL repository\u2014new features and functionality","volume":"45","author":"Bienert","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2026.118624_bb0145","first-page":"1709","article-title":"A mild one-pot method for conversion of various steroidal secondary alcohols into the corresponding olefins","volume":"12","author":"Kumar","year":"2011","journal-title":"Synlett"},{"key":"10.1016\/j.bmc.2026.118624_bb0150","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0968-0896(98)00119-9","article-title":"Synthesis and biological evaluation of 2-Hydroxy derivatives of digitoxigenin and 3-epidigitoxigenin","volume":"6","author":"Gobbini","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2026.118624_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J Comput-Aided Mol Des"},{"key":"10.1016\/j.bmc.2026.118624_bb0165","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2026.118624_bb0170","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118624_bb0175","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDock 2024: major enhancements for small-molecule docking with attracting cavities and AutoDock Vina","volume":"52","author":"Bugnon","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2026.118624_bb0180","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s00216-020-02494-y","article-title":"Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system","volume":"412","author":"Xue","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bmc.2026.118624_bb0185","doi-asserted-by":"crossref","first-page":"28474","DOI":"10.1021\/acsami.5b09573","article-title":"A two-photon ratiometric fluorescent probe for imaging carboxylesterase 2 in living cells and tissues","volume":"7","author":"Jin","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bmc.2026.118624_bb0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ab.2014.05.031","article-title":"Optimal detection of cholinesterase activity in biological samples: modifications to the standard Ellman\u2019s assay","volume":"462","author":"Dingova","year":"2014","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2026.118624_bb0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2026.118624_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bioorg.2013.06.008","article-title":"Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors","volume":"49","author":"Yoon","year":"2013","journal-title":"Bioorg Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:00:30Z","timestamp":1779426030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0968089626000805"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118624","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and characterization of steroid derivatives as hCES2A inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118624"}}